Pharma Journalist -

Exegenesis Bio and Modalis Therapeutics have entered a research collaboration and license agreement to advance MDL-201, an experimental treatment candidate for Duchenne muscular…
Read More...

Leading model-informed drug development experts to unite in Boston to explore pharmacometrics, AI, quantitative systems pharmacology, and evolving regulatory expectations The 2nd…
Read More...

With one week remaining until the 4th TRP Supply Chain & Manufacturing Summit, senior leaders from across the radiopharmaceutical industry are preparing to gather in Boston to…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Etcamah (camizestrant) for certain adults with advanced breast cancer, expanding treatment…
Read More...

AtomVie Global Radiopharma (AtomVie) has officially opened a new radiopharmaceutical manufacturing facility in Hamilton, Ontario, marking a major expansion of its production…
Read More...

Aptar Pharma has partnered with Aceso Therapeutics to support the development of ACT-101, an antisense oligonucleotide (ASO) candidate being developed as a potential treatment for…
Read More...

The 9th Annual RNA-Targeted Drug Discovery & Development Summit will unite the scientists, drug developers, and industry leaders advancing RNA-targeted small molecules from early…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Ionis Pharmaceuticals’ ZANVASTRO™ (zilganersen) for the treatment of Alexander disease (AxD) in pediatric and adult patients.…
Read More...

GSK has reported positive Phase II results for its mRNA seasonal influenza vaccine candidate, with the company planning to begin a Phase III efficacy trial in September 2026. The…
Read More...

Médunik Canada has entered into an exclusive promotional services agreement with Biocodex for Diacomit®, a treatment used for seizures associated with Dravet syndrome in Canada.…
Read More...